Global Long Acting Drug Delivery Market Research Report 2024(Status and Outlook)
Report Overview:
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
The Global Long Acting Drug Delivery Market Size was estimated at USD 1625.37 million in 2023 and is projected to reach USD 2292.60 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Long Acting Drug Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long Acting Drug Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long Acting Drug Delivery market in any manner.
Global Long Acting Drug Delivery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Market Segmentation (by Type)
Device
Parenteral Injections
Market Segmentation (by Application)
Hospital
Specialty Clinics
Clinical Research Institutes
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long Acting Drug Delivery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
The Global Long Acting Drug Delivery Market Size was estimated at USD 1625.37 million in 2023 and is projected to reach USD 2292.60 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Long Acting Drug Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long Acting Drug Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long Acting Drug Delivery market in any manner.
Global Long Acting Drug Delivery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Market Segmentation (by Type)
Device
Parenteral Injections
Market Segmentation (by Application)
Hospital
Specialty Clinics
Clinical Research Institutes
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Long Acting Drug Delivery Market
- Overview of the regional outlook of the Long Acting Drug Delivery Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long Acting Drug Delivery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Long Acting Drug Delivery
1.2 Key Market Segments
1.2.1 Long Acting Drug Delivery Segment by Type
1.2.2 Long Acting Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG ACTING DRUG DELIVERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long Acting Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Long Acting Drug Delivery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG ACTING DRUG DELIVERY MARKET COMPETITIVE LANDSCAPE
3.1 Global Long Acting Drug Delivery Sales by Manufacturers (2019-2024)
3.2 Global Long Acting Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
3.3 Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long Acting Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Long Acting Drug Delivery Sales Sites, Area Served, Product Type
3.6 Long Acting Drug Delivery Market Competitive Situation and Trends
3.6.1 Long Acting Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long Acting Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LONG ACTING DRUG DELIVERY INDUSTRY CHAIN ANALYSIS
4.1 Long Acting Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG ACTING DRUG DELIVERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LONG ACTING DRUG DELIVERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long Acting Drug Delivery Sales Market Share by Type (2019-2024)
6.3 Global Long Acting Drug Delivery Market Size Market Share by Type (2019-2024)
6.4 Global Long Acting Drug Delivery Price by Type (2019-2024)
7 LONG ACTING DRUG DELIVERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long Acting Drug Delivery Market Sales by Application (2019-2024)
7.3 Global Long Acting Drug Delivery Market Size (M USD) by Application (2019-2024)
7.4 Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2024)
8 LONG ACTING DRUG DELIVERY MARKET SEGMENTATION BY REGION
8.1 Global Long Acting Drug Delivery Sales by Region
8.1.1 Global Long Acting Drug Delivery Sales by Region
8.1.2 Global Long Acting Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Long Acting Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long Acting Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long Acting Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long Acting Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long Acting Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ViiV Healthcare
9.1.1 ViiV Healthcare Long Acting Drug Delivery Basic Information
9.1.2 ViiV Healthcare Long Acting Drug Delivery Product Overview
9.1.3 ViiV Healthcare Long Acting Drug Delivery Product Market Performance
9.1.4 ViiV Healthcare Business Overview
9.1.5 ViiV Healthcare Long Acting Drug Delivery SWOT Analysis
9.1.6 ViiV Healthcare Recent Developments
9.2 Halozyme Therapeutics
9.2.1 Halozyme Therapeutics Long Acting Drug Delivery Basic Information
9.2.2 Halozyme Therapeutics Long Acting Drug Delivery Product Overview
9.2.3 Halozyme Therapeutics Long Acting Drug Delivery Product Market Performance
9.2.4 Halozyme Therapeutics Business Overview
9.2.5 Halozyme Therapeutics Long Acting Drug Delivery SWOT Analysis
9.2.6 Halozyme Therapeutics Recent Developments
9.3 Lubrizol Life Science
9.3.1 Lubrizol Life Science Long Acting Drug Delivery Basic Information
9.3.2 Lubrizol Life Science Long Acting Drug Delivery Product Overview
9.3.3 Lubrizol Life Science Long Acting Drug Delivery Product Market Performance
9.3.4 Lubrizol Life Science Long Acting Drug Delivery SWOT Analysis
9.3.5 Lubrizol Life Science Business Overview
9.3.6 Lubrizol Life Science Recent Developments
9.4 Celanese Corporation
9.4.1 Celanese Corporation Long Acting Drug Delivery Basic Information
9.4.2 Celanese Corporation Long Acting Drug Delivery Product Overview
9.4.3 Celanese Corporation Long Acting Drug Delivery Product Market Performance
9.4.4 Celanese Corporation Business Overview
9.4.5 Celanese Corporation Recent Developments
9.5 Kashiv BioSciences
9.5.1 Kashiv BioSciences Long Acting Drug Delivery Basic Information
9.5.2 Kashiv BioSciences Long Acting Drug Delivery Product Overview
9.5.3 Kashiv BioSciences Long Acting Drug Delivery Product Market Performance
9.5.4 Kashiv BioSciences Business Overview
9.5.5 Kashiv BioSciences Recent Developments
9.6 4P Therapeutics
9.6.1 4P Therapeutics Long Acting Drug Delivery Basic Information
9.6.2 4P Therapeutics Long Acting Drug Delivery Product Overview
9.6.3 4P Therapeutics Long Acting Drug Delivery Product Market Performance
9.6.4 4P Therapeutics Business Overview
9.6.5 4P Therapeutics Recent Developments
9.7 Ipsen
9.7.1 Ipsen Long Acting Drug Delivery Basic Information
9.7.2 Ipsen Long Acting Drug Delivery Product Overview
9.7.3 Ipsen Long Acting Drug Delivery Product Market Performance
9.7.4 Ipsen Business Overview
9.7.5 Ipsen Recent Developments
9.8 Midatech Pharma
9.8.1 Midatech Pharma Long Acting Drug Delivery Basic Information
9.8.2 Midatech Pharma Long Acting Drug Delivery Product Overview
9.8.3 Midatech Pharma Long Acting Drug Delivery Product Market Performance
9.8.4 Midatech Pharma Business Overview
9.8.5 Midatech Pharma Recent Developments
9.9 Re-Vana Therapeutics
9.9.1 Re-Vana Therapeutics Long Acting Drug Delivery Basic Information
9.9.2 Re-Vana Therapeutics Long Acting Drug Delivery Product Overview
9.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Product Market Performance
9.9.4 Re-Vana Therapeutics Business Overview
9.9.5 Re-Vana Therapeutics Recent Developments
9.10 Creative Biolabs
9.10.1 Creative Biolabs Long Acting Drug Delivery Basic Information
9.10.2 Creative Biolabs Long Acting Drug Delivery Product Overview
9.10.3 Creative Biolabs Long Acting Drug Delivery Product Market Performance
9.10.4 Creative Biolabs Business Overview
9.10.5 Creative Biolabs Recent Developments
10 LONG ACTING DRUG DELIVERY MARKET FORECAST BY REGION
10.1 Global Long Acting Drug Delivery Market Size Forecast
10.2 Global Long Acting Drug Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Long Acting Drug Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Long Acting Drug Delivery Market Size Forecast by Region
10.2.4 South America Long Acting Drug Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Long Acting Drug Delivery by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Long Acting Drug Delivery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Long Acting Drug Delivery by Type (2025-2030)
11.1.2 Global Long Acting Drug Delivery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Long Acting Drug Delivery by Type (2025-2030)
11.2 Global Long Acting Drug Delivery Market Forecast by Application (2025-2030)
11.2.1 Global Long Acting Drug Delivery Sales (K Units) Forecast by Application
11.2.2 Global Long Acting Drug Delivery Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Long Acting Drug Delivery
1.2 Key Market Segments
1.2.1 Long Acting Drug Delivery Segment by Type
1.2.2 Long Acting Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG ACTING DRUG DELIVERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long Acting Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Long Acting Drug Delivery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG ACTING DRUG DELIVERY MARKET COMPETITIVE LANDSCAPE
3.1 Global Long Acting Drug Delivery Sales by Manufacturers (2019-2024)
3.2 Global Long Acting Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
3.3 Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long Acting Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Long Acting Drug Delivery Sales Sites, Area Served, Product Type
3.6 Long Acting Drug Delivery Market Competitive Situation and Trends
3.6.1 Long Acting Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long Acting Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LONG ACTING DRUG DELIVERY INDUSTRY CHAIN ANALYSIS
4.1 Long Acting Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG ACTING DRUG DELIVERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LONG ACTING DRUG DELIVERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long Acting Drug Delivery Sales Market Share by Type (2019-2024)
6.3 Global Long Acting Drug Delivery Market Size Market Share by Type (2019-2024)
6.4 Global Long Acting Drug Delivery Price by Type (2019-2024)
7 LONG ACTING DRUG DELIVERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long Acting Drug Delivery Market Sales by Application (2019-2024)
7.3 Global Long Acting Drug Delivery Market Size (M USD) by Application (2019-2024)
7.4 Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2024)
8 LONG ACTING DRUG DELIVERY MARKET SEGMENTATION BY REGION
8.1 Global Long Acting Drug Delivery Sales by Region
8.1.1 Global Long Acting Drug Delivery Sales by Region
8.1.2 Global Long Acting Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Long Acting Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long Acting Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long Acting Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long Acting Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long Acting Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ViiV Healthcare
9.1.1 ViiV Healthcare Long Acting Drug Delivery Basic Information
9.1.2 ViiV Healthcare Long Acting Drug Delivery Product Overview
9.1.3 ViiV Healthcare Long Acting Drug Delivery Product Market Performance
9.1.4 ViiV Healthcare Business Overview
9.1.5 ViiV Healthcare Long Acting Drug Delivery SWOT Analysis
9.1.6 ViiV Healthcare Recent Developments
9.2 Halozyme Therapeutics
9.2.1 Halozyme Therapeutics Long Acting Drug Delivery Basic Information
9.2.2 Halozyme Therapeutics Long Acting Drug Delivery Product Overview
9.2.3 Halozyme Therapeutics Long Acting Drug Delivery Product Market Performance
9.2.4 Halozyme Therapeutics Business Overview
9.2.5 Halozyme Therapeutics Long Acting Drug Delivery SWOT Analysis
9.2.6 Halozyme Therapeutics Recent Developments
9.3 Lubrizol Life Science
9.3.1 Lubrizol Life Science Long Acting Drug Delivery Basic Information
9.3.2 Lubrizol Life Science Long Acting Drug Delivery Product Overview
9.3.3 Lubrizol Life Science Long Acting Drug Delivery Product Market Performance
9.3.4 Lubrizol Life Science Long Acting Drug Delivery SWOT Analysis
9.3.5 Lubrizol Life Science Business Overview
9.3.6 Lubrizol Life Science Recent Developments
9.4 Celanese Corporation
9.4.1 Celanese Corporation Long Acting Drug Delivery Basic Information
9.4.2 Celanese Corporation Long Acting Drug Delivery Product Overview
9.4.3 Celanese Corporation Long Acting Drug Delivery Product Market Performance
9.4.4 Celanese Corporation Business Overview
9.4.5 Celanese Corporation Recent Developments
9.5 Kashiv BioSciences
9.5.1 Kashiv BioSciences Long Acting Drug Delivery Basic Information
9.5.2 Kashiv BioSciences Long Acting Drug Delivery Product Overview
9.5.3 Kashiv BioSciences Long Acting Drug Delivery Product Market Performance
9.5.4 Kashiv BioSciences Business Overview
9.5.5 Kashiv BioSciences Recent Developments
9.6 4P Therapeutics
9.6.1 4P Therapeutics Long Acting Drug Delivery Basic Information
9.6.2 4P Therapeutics Long Acting Drug Delivery Product Overview
9.6.3 4P Therapeutics Long Acting Drug Delivery Product Market Performance
9.6.4 4P Therapeutics Business Overview
9.6.5 4P Therapeutics Recent Developments
9.7 Ipsen
9.7.1 Ipsen Long Acting Drug Delivery Basic Information
9.7.2 Ipsen Long Acting Drug Delivery Product Overview
9.7.3 Ipsen Long Acting Drug Delivery Product Market Performance
9.7.4 Ipsen Business Overview
9.7.5 Ipsen Recent Developments
9.8 Midatech Pharma
9.8.1 Midatech Pharma Long Acting Drug Delivery Basic Information
9.8.2 Midatech Pharma Long Acting Drug Delivery Product Overview
9.8.3 Midatech Pharma Long Acting Drug Delivery Product Market Performance
9.8.4 Midatech Pharma Business Overview
9.8.5 Midatech Pharma Recent Developments
9.9 Re-Vana Therapeutics
9.9.1 Re-Vana Therapeutics Long Acting Drug Delivery Basic Information
9.9.2 Re-Vana Therapeutics Long Acting Drug Delivery Product Overview
9.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Product Market Performance
9.9.4 Re-Vana Therapeutics Business Overview
9.9.5 Re-Vana Therapeutics Recent Developments
9.10 Creative Biolabs
9.10.1 Creative Biolabs Long Acting Drug Delivery Basic Information
9.10.2 Creative Biolabs Long Acting Drug Delivery Product Overview
9.10.3 Creative Biolabs Long Acting Drug Delivery Product Market Performance
9.10.4 Creative Biolabs Business Overview
9.10.5 Creative Biolabs Recent Developments
10 LONG ACTING DRUG DELIVERY MARKET FORECAST BY REGION
10.1 Global Long Acting Drug Delivery Market Size Forecast
10.2 Global Long Acting Drug Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Long Acting Drug Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Long Acting Drug Delivery Market Size Forecast by Region
10.2.4 South America Long Acting Drug Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Long Acting Drug Delivery by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Long Acting Drug Delivery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Long Acting Drug Delivery by Type (2025-2030)
11.1.2 Global Long Acting Drug Delivery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Long Acting Drug Delivery by Type (2025-2030)
11.2 Global Long Acting Drug Delivery Market Forecast by Application (2025-2030)
11.2.1 Global Long Acting Drug Delivery Sales (K Units) Forecast by Application
11.2.2 Global Long Acting Drug Delivery Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long Acting Drug Delivery Market Size Comparison by Region (M USD)
Table 5. Global Long Acting Drug Delivery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Long Acting Drug Delivery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Long Acting Drug Delivery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Long Acting Drug Delivery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2022)
Table 10. Global Market Long Acting Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Long Acting Drug Delivery Sales Sites and Area Served
Table 12. Manufacturers Long Acting Drug Delivery Product Type
Table 13. Global Long Acting Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long Acting Drug Delivery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long Acting Drug Delivery Market Challenges
Table 22. Global Long Acting Drug Delivery Sales by Type (K Units)
Table 23. Global Long Acting Drug Delivery Market Size by Type (M USD)
Table 24. Global Long Acting Drug Delivery Sales (K Units) by Type (2019-2024)
Table 25. Global Long Acting Drug Delivery Sales Market Share by Type (2019-2024)
Table 26. Global Long Acting Drug Delivery Market Size (M USD) by Type (2019-2024)
Table 27. Global Long Acting Drug Delivery Market Size Share by Type (2019-2024)
Table 28. Global Long Acting Drug Delivery Price (USD/Unit) by Type (2019-2024)
Table 29. Global Long Acting Drug Delivery Sales (K Units) by Application
Table 30. Global Long Acting Drug Delivery Market Size by Application
Table 31. Global Long Acting Drug Delivery Sales by Application (2019-2024) & (K Units)
Table 32. Global Long Acting Drug Delivery Sales Market Share by Application (2019-2024)
Table 33. Global Long Acting Drug Delivery Sales by Application (2019-2024) & (M USD)
Table 34. Global Long Acting Drug Delivery Market Share by Application (2019-2024)
Table 35. Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2024)
Table 36. Global Long Acting Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 37. Global Long Acting Drug Delivery Sales Market Share by Region (2019-2024)
Table 38. North America Long Acting Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 39. Europe Long Acting Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Long Acting Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 41. South America Long Acting Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Long Acting Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 43. ViiV Healthcare Long Acting Drug Delivery Basic Information
Table 44. ViiV Healthcare Long Acting Drug Delivery Product Overview
Table 45. ViiV Healthcare Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. ViiV Healthcare Business Overview
Table 47. ViiV Healthcare Long Acting Drug Delivery SWOT Analysis
Table 48. ViiV Healthcare Recent Developments
Table 49. Halozyme Therapeutics Long Acting Drug Delivery Basic Information
Table 50. Halozyme Therapeutics Long Acting Drug Delivery Product Overview
Table 51. Halozyme Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Halozyme Therapeutics Business Overview
Table 53. Halozyme Therapeutics Long Acting Drug Delivery SWOT Analysis
Table 54. Halozyme Therapeutics Recent Developments
Table 55. Lubrizol Life Science Long Acting Drug Delivery Basic Information
Table 56. Lubrizol Life Science Long Acting Drug Delivery Product Overview
Table 57. Lubrizol Life Science Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Lubrizol Life Science Long Acting Drug Delivery SWOT Analysis
Table 59. Lubrizol Life Science Business Overview
Table 60. Lubrizol Life Science Recent Developments
Table 61. Celanese Corporation Long Acting Drug Delivery Basic Information
Table 62. Celanese Corporation Long Acting Drug Delivery Product Overview
Table 63. Celanese Corporation Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Celanese Corporation Business Overview
Table 65. Celanese Corporation Recent Developments
Table 66. Kashiv BioSciences Long Acting Drug Delivery Basic Information
Table 67. Kashiv BioSciences Long Acting Drug Delivery Product Overview
Table 68. Kashiv BioSciences Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Kashiv BioSciences Business Overview
Table 70. Kashiv BioSciences Recent Developments
Table 71. 4P Therapeutics Long Acting Drug Delivery Basic Information
Table 72. 4P Therapeutics Long Acting Drug Delivery Product Overview
Table 73. 4P Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. 4P Therapeutics Business Overview
Table 75. 4P Therapeutics Recent Developments
Table 76. Ipsen Long Acting Drug Delivery Basic Information
Table 77. Ipsen Long Acting Drug Delivery Product Overview
Table 78. Ipsen Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Ipsen Business Overview
Table 80. Ipsen Recent Developments
Table 81. Midatech Pharma Long Acting Drug Delivery Basic Information
Table 82. Midatech Pharma Long Acting Drug Delivery Product Overview
Table 83. Midatech Pharma Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Midatech Pharma Business Overview
Table 85. Midatech Pharma Recent Developments
Table 86. Re-Vana Therapeutics Long Acting Drug Delivery Basic Information
Table 87. Re-Vana Therapeutics Long Acting Drug Delivery Product Overview
Table 88. Re-Vana Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Re-Vana Therapeutics Business Overview
Table 90. Re-Vana Therapeutics Recent Developments
Table 91. Creative Biolabs Long Acting Drug Delivery Basic Information
Table 92. Creative Biolabs Long Acting Drug Delivery Product Overview
Table 93. Creative Biolabs Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Creative Biolabs Business Overview
Table 95. Creative Biolabs Recent Developments
Table 96. Global Long Acting Drug Delivery Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Long Acting Drug Delivery Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Long Acting Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Long Acting Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Long Acting Drug Delivery Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Long Acting Drug Delivery Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Long Acting Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Long Acting Drug Delivery Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Long Acting Drug Delivery Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Long Acting Drug Delivery Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Long Acting Drug Delivery Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Long Acting Drug Delivery Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Long Acting Drug Delivery Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long Acting Drug Delivery Market Size Comparison by Region (M USD)
Table 5. Global Long Acting Drug Delivery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Long Acting Drug Delivery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Long Acting Drug Delivery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Long Acting Drug Delivery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2022)
Table 10. Global Market Long Acting Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Long Acting Drug Delivery Sales Sites and Area Served
Table 12. Manufacturers Long Acting Drug Delivery Product Type
Table 13. Global Long Acting Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long Acting Drug Delivery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long Acting Drug Delivery Market Challenges
Table 22. Global Long Acting Drug Delivery Sales by Type (K Units)
Table 23. Global Long Acting Drug Delivery Market Size by Type (M USD)
Table 24. Global Long Acting Drug Delivery Sales (K Units) by Type (2019-2024)
Table 25. Global Long Acting Drug Delivery Sales Market Share by Type (2019-2024)
Table 26. Global Long Acting Drug Delivery Market Size (M USD) by Type (2019-2024)
Table 27. Global Long Acting Drug Delivery Market Size Share by Type (2019-2024)
Table 28. Global Long Acting Drug Delivery Price (USD/Unit) by Type (2019-2024)
Table 29. Global Long Acting Drug Delivery Sales (K Units) by Application
Table 30. Global Long Acting Drug Delivery Market Size by Application
Table 31. Global Long Acting Drug Delivery Sales by Application (2019-2024) & (K Units)
Table 32. Global Long Acting Drug Delivery Sales Market Share by Application (2019-2024)
Table 33. Global Long Acting Drug Delivery Sales by Application (2019-2024) & (M USD)
Table 34. Global Long Acting Drug Delivery Market Share by Application (2019-2024)
Table 35. Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2024)
Table 36. Global Long Acting Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 37. Global Long Acting Drug Delivery Sales Market Share by Region (2019-2024)
Table 38. North America Long Acting Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 39. Europe Long Acting Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Long Acting Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 41. South America Long Acting Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Long Acting Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 43. ViiV Healthcare Long Acting Drug Delivery Basic Information
Table 44. ViiV Healthcare Long Acting Drug Delivery Product Overview
Table 45. ViiV Healthcare Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. ViiV Healthcare Business Overview
Table 47. ViiV Healthcare Long Acting Drug Delivery SWOT Analysis
Table 48. ViiV Healthcare Recent Developments
Table 49. Halozyme Therapeutics Long Acting Drug Delivery Basic Information
Table 50. Halozyme Therapeutics Long Acting Drug Delivery Product Overview
Table 51. Halozyme Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Halozyme Therapeutics Business Overview
Table 53. Halozyme Therapeutics Long Acting Drug Delivery SWOT Analysis
Table 54. Halozyme Therapeutics Recent Developments
Table 55. Lubrizol Life Science Long Acting Drug Delivery Basic Information
Table 56. Lubrizol Life Science Long Acting Drug Delivery Product Overview
Table 57. Lubrizol Life Science Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Lubrizol Life Science Long Acting Drug Delivery SWOT Analysis
Table 59. Lubrizol Life Science Business Overview
Table 60. Lubrizol Life Science Recent Developments
Table 61. Celanese Corporation Long Acting Drug Delivery Basic Information
Table 62. Celanese Corporation Long Acting Drug Delivery Product Overview
Table 63. Celanese Corporation Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Celanese Corporation Business Overview
Table 65. Celanese Corporation Recent Developments
Table 66. Kashiv BioSciences Long Acting Drug Delivery Basic Information
Table 67. Kashiv BioSciences Long Acting Drug Delivery Product Overview
Table 68. Kashiv BioSciences Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Kashiv BioSciences Business Overview
Table 70. Kashiv BioSciences Recent Developments
Table 71. 4P Therapeutics Long Acting Drug Delivery Basic Information
Table 72. 4P Therapeutics Long Acting Drug Delivery Product Overview
Table 73. 4P Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. 4P Therapeutics Business Overview
Table 75. 4P Therapeutics Recent Developments
Table 76. Ipsen Long Acting Drug Delivery Basic Information
Table 77. Ipsen Long Acting Drug Delivery Product Overview
Table 78. Ipsen Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Ipsen Business Overview
Table 80. Ipsen Recent Developments
Table 81. Midatech Pharma Long Acting Drug Delivery Basic Information
Table 82. Midatech Pharma Long Acting Drug Delivery Product Overview
Table 83. Midatech Pharma Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Midatech Pharma Business Overview
Table 85. Midatech Pharma Recent Developments
Table 86. Re-Vana Therapeutics Long Acting Drug Delivery Basic Information
Table 87. Re-Vana Therapeutics Long Acting Drug Delivery Product Overview
Table 88. Re-Vana Therapeutics Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Re-Vana Therapeutics Business Overview
Table 90. Re-Vana Therapeutics Recent Developments
Table 91. Creative Biolabs Long Acting Drug Delivery Basic Information
Table 92. Creative Biolabs Long Acting Drug Delivery Product Overview
Table 93. Creative Biolabs Long Acting Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Creative Biolabs Business Overview
Table 95. Creative Biolabs Recent Developments
Table 96. Global Long Acting Drug Delivery Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Long Acting Drug Delivery Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Long Acting Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Long Acting Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Long Acting Drug Delivery Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Long Acting Drug Delivery Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Long Acting Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Long Acting Drug Delivery Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Long Acting Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Long Acting Drug Delivery Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Long Acting Drug Delivery Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Long Acting Drug Delivery Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Long Acting Drug Delivery Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Long Acting Drug Delivery Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Long Acting Drug Delivery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long Acting Drug Delivery Market Size (M USD), 2019-2030
Figure 5. Global Long Acting Drug Delivery Market Size (M USD) (2019-2030)
Figure 6. Global Long Acting Drug Delivery Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long Acting Drug Delivery Market Size by Country (M USD)
Figure 11. Long Acting Drug Delivery Sales Share by Manufacturers in 2023
Figure 12. Global Long Acting Drug Delivery Revenue Share by Manufacturers in 2023
Figure 13. Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long Acting Drug Delivery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long Acting Drug Delivery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long Acting Drug Delivery Market Share by Type
Figure 18. Sales Market Share of Long Acting Drug Delivery by Type (2019-2024)
Figure 19. Sales Market Share of Long Acting Drug Delivery by Type in 2023
Figure 20. Market Size Share of Long Acting Drug Delivery by Type (2019-2024)
Figure 21. Market Size Market Share of Long Acting Drug Delivery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long Acting Drug Delivery Market Share by Application
Figure 24. Global Long Acting Drug Delivery Sales Market Share by Application (2019-2024)
Figure 25. Global Long Acting Drug Delivery Sales Market Share by Application in 2023
Figure 26. Global Long Acting Drug Delivery Market Share by Application (2019-2024)
Figure 27. Global Long Acting Drug Delivery Market Share by Application in 2023
Figure 28. Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2024)
Figure 29. Global Long Acting Drug Delivery Sales Market Share by Region (2019-2024)
Figure 30. North America Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 32. U.S. Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Long Acting Drug Delivery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Long Acting Drug Delivery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 37. Germany Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Long Acting Drug Delivery Sales Market Share by Region in 2023
Figure 44. China Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 50. South America Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 51. Brazil Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Long Acting Drug Delivery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Long Acting Drug Delivery Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Long Acting Drug Delivery Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Long Acting Drug Delivery Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Long Acting Drug Delivery Market Share Forecast by Type (2025-2030)
Figure 65. Global Long Acting Drug Delivery Sales Forecast by Application (2025-2030)
Figure 66. Global Long Acting Drug Delivery Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Long Acting Drug Delivery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long Acting Drug Delivery Market Size (M USD), 2019-2030
Figure 5. Global Long Acting Drug Delivery Market Size (M USD) (2019-2030)
Figure 6. Global Long Acting Drug Delivery Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long Acting Drug Delivery Market Size by Country (M USD)
Figure 11. Long Acting Drug Delivery Sales Share by Manufacturers in 2023
Figure 12. Global Long Acting Drug Delivery Revenue Share by Manufacturers in 2023
Figure 13. Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long Acting Drug Delivery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long Acting Drug Delivery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long Acting Drug Delivery Market Share by Type
Figure 18. Sales Market Share of Long Acting Drug Delivery by Type (2019-2024)
Figure 19. Sales Market Share of Long Acting Drug Delivery by Type in 2023
Figure 20. Market Size Share of Long Acting Drug Delivery by Type (2019-2024)
Figure 21. Market Size Market Share of Long Acting Drug Delivery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long Acting Drug Delivery Market Share by Application
Figure 24. Global Long Acting Drug Delivery Sales Market Share by Application (2019-2024)
Figure 25. Global Long Acting Drug Delivery Sales Market Share by Application in 2023
Figure 26. Global Long Acting Drug Delivery Market Share by Application (2019-2024)
Figure 27. Global Long Acting Drug Delivery Market Share by Application in 2023
Figure 28. Global Long Acting Drug Delivery Sales Growth Rate by Application (2019-2024)
Figure 29. Global Long Acting Drug Delivery Sales Market Share by Region (2019-2024)
Figure 30. North America Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 32. U.S. Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Long Acting Drug Delivery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Long Acting Drug Delivery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 37. Germany Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Long Acting Drug Delivery Sales Market Share by Region in 2023
Figure 44. China Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 50. South America Long Acting Drug Delivery Sales Market Share by Country in 2023
Figure 51. Brazil Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Long Acting Drug Delivery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Long Acting Drug Delivery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Long Acting Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Long Acting Drug Delivery Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Long Acting Drug Delivery Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Long Acting Drug Delivery Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Long Acting Drug Delivery Market Share Forecast by Type (2025-2030)
Figure 65. Global Long Acting Drug Delivery Sales Forecast by Application (2025-2030)
Figure 66. Global Long Acting Drug Delivery Market Share Forecast by Application (2025-2030)
